Merrimack Pharmaceuticals (MACK) Competitor Comparison
We are evaluating the key criteria listed to compare Merrimack Pharmaceuticals (MACK) against its competitors in the Biotechnology industry.
Market Capitalization
222 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
0 / 337Free Cashflow
40 / 352Quick Ratio
5 / 357Earnings per Share
47 / 359Dividend yield
2 / 6Total Cash
301 / 358Performance 3 years
37 / 368Performance 5 years
38 / 368Performance 10 years
190 / 368Linearity 3 years
335 / 368Linearity 5 years
360 / 368Linearity 10 years
185 / 367Total Rank
195 / 368Dividend Rank
201 / 368Valuation Rank
74 / 368Piotroski Rank
336 / 368Muliplier Rank
83 / 368Market Capitalization - MACK ranking 222 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.